To test this, using antibody arrays, we examined the secretion levels of 36 different cytokines (Additional file 2: Table S1) in the supernatants of triple-negative breast cancer (TNBC) MDA-MB-231 cells, and ER+/PR+/HER2− MCF-7 cells, treated for 24 h with either hydrolysis products generated by LPL, or mock control media (without LPL). The gene discussed is LPL; the disease is triple-negative breast carcinoma.